Severe Acute Respiratory Syndrome

Avian influenza prevention tips and how to handle an outbreak - FarmersWeekly Avian influenza prevention tips and how to handle an outbreak - FarmersWeekly Posted: 30 Oct 2020 11:35 PM PDT © Tim Scrivener Avian flu is every poultry producer's worst fear; infection can cause widespread mortality, and confirmation of the disease will usually trigger a cull of the flock, followed by stringent cleaning and disinfection measures. Producers are not able to restock until at least 21 days after the clean-down has been approved, and movement restrictions will be put into place. Although there is compensation available for slaughtered birds, any that die naturally from the disease are not paid for, so losses can be considerable. See also: Avian influenza: One farm's robust plans to combat the threat General biosecurity considerations The disease is spread by direct bird-to-bird contact, through contaminated ...

Have your kids immunized, DOH reminds parents anew - Manila Bulletin Have your kids immunized, DOH reminds parents anew - Manila Bulletin Posted: 11 Oct 2020 12:00 AM PDT The Department of Health (DOH) on Sunday, Oct. 11, encouraged parents yet again to have their children immunized against vaccine-preventable diseases such as measles and polio.  The DOH is set to conduct a supplemental immunization campaign starting Oct. 26. "While all of us rightfully remain vigilant about COVID-19, we have to be equally mindful as well when it comes to diseases like measles, rubella, and polio," said Health Secretary Francisco Duque III.  "Our children need protection from these diseases, and this can be given through proper vaccination. We invite our parents to join this campaign to protect their families' health," he added.  Health Undersecretary Maria Rosario Vergeire said that measles has a lot of complications and may lead...

“Evaluation of PEEP and prone positioning in early COVID-19 ARDS - The Lancet” plus 2 more Evaluation of PEEP and prone positioning in early COVID-19 ARDS - The Lancet A Preclinical safety study of thyroid hormone instilled into the lungs of healthy rats - an investigational therapy for ARDS - DocWire News AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 to ImStem Biotechnology for Development of Cell Therapy Candidate IMS001 for COVID-19 and Acute Respiratory Distress Syndrome - BioSpace Evaluation of PEEP and prone positioning in early COVID-19 ARDS - The Lancet Posted: 10 Oct 2020 12:00 AM PDT [unable to retrieve full-text content] Evaluation of PEEP and prone positioning in early COVID-19 ARDS    The Lancet A Preclinical safety study of thyroid hormone instilled into the lungs of healthy rats - an investigational therapy for ARDS - DocWire News Posted: 30 Oct 2020 11:00 PM P...

Coronavirus Tracker: Bexar Co. finishes October with 8,000+ cases for the month    KENS5.com

Scientists Are Making Music From SARS-CoV-2 Coronavirus Genetic Code    Forbes

SARS-CoV-2 Seroprevalence in a Nationwide Sample of Dialysis Patients    Infectious Disease Advisor

Ask the Doctors: COVID-19 'long-haulers' feel effects long after recovery    Santa Maria Times

Worldwide Industry for Aerosol Delivery Devices to 2027 - Increase in Prevalence of COPD and Asthma is Driving Growth - GlobeNewswire Worldwide Industry for Aerosol Delivery Devices to 2027 - Increase in Prevalence of COPD and Asthma is Driving Growth - GlobeNewswire Posted: 16 Oct 2020 12:00 AM PDT Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Aerosol Delivery Devices Market by Product, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets. It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities. A comprehensive analysis of four regions is provided to determine the existing oppor...

Coronavirus Test Kits Market Trends, Size, Share, Growth, Demand, Business Opportunity, Top Companie - PharmiWeb.com Coronavirus Test Kits Market Trends, Size, Share, Growth, Demand, Business Opportunity, Top Companie - PharmiWeb.com Posted: 26 Oct 2020 02:45 AM PDT A recently announced report titled Global Coronavirus Test Kits Market Size, Share, Growth, Industry Trends and Forecast 2027 by Data Bridge Market Research aims to deliver a detailed investigation of all necessary data related to the global market. Coronavirus Test Kits Industry Research Report is an in-depth and deep Research on the present condition of the Coronavirus Test Kits industry in the global market. Furthermore, this Report presents a detailed overview, cost structure, size, revenue, growth, share, dynamics, competitive analysis, Companies and Coronavirus Test Kits strategy & statistics analysis. This Report is segmented on basis of product type, end-user, applicat...

“Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties - The Lancet” plus 1 more Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties - The Lancet Posted: 29 Oct 2020 04:36 PM PDT [unable to retrieve full-text content] Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties    The Lancet DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats - Global Biodefense Posted: 31 Oct 2020 02:40 PM PDT The rapid availability of effective medical countermeasures against chemical exposures, from either accidents or chemical weapons attack, is critical in the treatment of their acute health effects following exposures. The ReDIRECT Program is a new initiative from the Biomedical Advanced Research and Development Authority (BARDA) which aims to identify existing, commonly available therapeutics that can be used to...

“FDA anoints Gilead's remdesivir as the Covid-19 treatment winner, handing down full approval — despite some deep skepticism - Endpoints News” plus 1 more FDA anoints Gilead's remdesivir as the Covid-19 treatment winner, handing down full approval — despite some deep skepticism - Endpoints News Posted: 22 Oct 2020 02:09 PM PDT In January, when dozens of scientists rushed to start making a vaccine for the then-novel coronavirus, they were joined by an unlikely compatriot: Patrick Soon-Shiong, the billionaire doctor most famous for making big, controversial promises on cancer research. Soon-Shiong had spent the last 4 years on his "Cancer Moonshot," but part of his project meant buying a small Seattle biotech that specialized in making common-cold vectors, called adenoviruses, to train the immune system. The billionaire had been using those vectors for oncology, but the company had also developed vaccin...

Transcriptomic analysis reveals novel mechanisms of SARS‐CoV‐2 infection in human lung cells - Wiley Transcriptomic analysis reveals novel mechanisms of SARS‐CoV‐2 infection in human lung cells - Wiley Posted: 30 Oct 2020 10:34 AM PDT 1 INTRODUCTION The prevalence of coronavirus disease‐2019 (COVID‐19), which is caused by severe acute respiratory syndrome coronavirus clade 2 (SARS‐CoV‐2), at the end of 2019 became a global pandemic. 1 According to the World Health Organization (WHO) data, the latest infection cases in the world have reached more than 37.4 million, with the reported deaths of more than 1,075,000 individuals. 2 Until now, the prevalence of COVID‐19 seems still to be increasing exponentially. Therefore, the effective approaches for the prevention and treatment of COVID‐19 are urgently needed. Coronaviruses are a family of enveloped, positive‐stranded RNA viruses, which can infect various vertebrate hosts, including bats, do...